Dyadic International, Inc. (NASDAQ:DYAI) Q2 2023 Earnings Conference Call August 9, 2023 5:00 PM ET

Company Participants

Ping Rawson - Chief Financial Officer

Mark Emalfarb - President and Chief Executive Officer

Joseph Hazelton - Chief Business Officer

Conference Call Participants

John Vandermosten - Zacks

Dick Williams - Williams Research Group

Robert Smith - Center for Performance Investing

Tony Bowers - Intro Act

Operator

Good evening, and welcome to Dyadic International's Second Quarter 2023 Financial Results Conference Call. Currently, all participants are in a listen-only mode. Following management’s prepared remarks, there will be a brief question-and-answer session. As a reminder, this conference call is being recorded today, August 09, 2023.

I would now like to turn the call over to Ms. Ping Rawson, Dyadic's Chief Financial Officer. Please go ahead.

Ping Rawson

Thank you. Good evening, and welcome, everyone, to Dyadic International's second quarter 2023 conference call. I hope you have had the opportunity to review Dyadic's press release announcing financial results for the quarter ended June 30, 2023, and the recent Company highlights. You may access our release and Form 10-Q under the Investors section of the Company's website at dyadic.com.

On today's call, our President and CEO, Mark Emalfarb, will give a review of our second quarter business and corporate highlights, including a summary of our recent research and business development efforts. Our Chief Business Officer, Joe Hazelton, will join Mark for the business updates. I will follow with a review of our financial results in more detail. We will then hold a brief Q&A session.

At this time, I would like to inform you that certain commentary made in this conference call may be considered forward-looking statements, which involve risks and uncertainties and other factors that could cause Dyadic's actual results, performance, scientific or otherwise or achievements to be materially different from those expressed or implied by these forward-looking statements. Dyadic expressly disclaims any duty to provide updates to its forward-looking statements, whether because of new information, future events or otherwise. Participants are directed to the risk factors set forth in Dyadic's reports filed with the SEC.

It is now my pleasure to pass the call to our CEO, Mark Emalfarb. Mark?

Mark Emalfarb

Thank you Ping. Hello, everyone, and thank you for joining Dyadic’s second quarter 2023 conference call.

We've continued the momentum seen in the first quarter of 2023 as our C1 technology continues to garner praise and recognition for its speed and efficiency in the U.S. and internationally for academia, industry, and government agencies. In addition, our Dapibus platform has gained significant traction in both the alternative protein and bioindustrial markets. We are delivering multiple new research collaborations and strong revenue growth of 38.5% year-over-year for the first six months of this year. On today's call, Joe and I will highlight the significant technological advances and recent business development successes we have and continue to achieve across each of our core markets. We're excited about our current and future prospects for growth and our revenues while continuing the ongoing long-term collaborations with Janssen, Februaryabic, Rubic, and others.